ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0973

VExUS.io: A Tool to Improve Adoption of Venous Excess Ultrasound (VExUS) Among Trainees

Session Information

  • Educational Research
    October 24, 2026 | Location: Exhibit Hall A, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Educational Research

  • 1000 Educational Research

Authors

  • Krieger, Adam, Tulane University School of Medicine, New Orleans, Louisiana, United States
  • Baudy, Adrian J., Tulane University School of Medicine, New Orleans, Louisiana, United States
Background

Venous congestion contributes to cardiorenal syndrome (CRS) and AKI, yet VExUS remains underutilized due to interpretive complexity and limited training. We developed VExUS.io, a web app, with VExUS grading, waveform and image references, probe-placement guidance, lung ultrasound integration, automated reporting, and an evidence summary.

Methods

In this prospective usability study, 37 internal medicine trainees used VExUS.io and completed a post-use survey assessing baseline familiarity, confidence, perceived utility, and barriers. Usability was assessed via the System Usability Scale (SUS).

Results

Baseline VExUS exposure was limited, with 42% of trainees reporting no prior familiarity, and 76% reporting no or novice Doppler POCUS experience. Mean SUS was 89.95, indicating excellent usability. Self-reported confidence in assigning a VExUS grade increased from 2.56 pre-use to 3.78 post-use (p<.001); confidence in appropriate clinical indications was 3.83 post-use. Participants agreed that the app reduced cognitive load (3.68), improved understanding of venous congestion/Doppler waveforms (3.69), and increased intent to use VExUS clinically (3.58). On knowledge items, 86% selected the appropriate clinical scenario for VExUS use, and 91% would escalate decongestive therapy for a grade 3 VExUS with AKI. Top barriers included lack of time (56%), difficulty interpreting images (39%), and limited ultrasound access (31%).

Conclusion

VExUS.io demonstrated excellent usability and significantly improved trainee confidence in VExUS grading, while also improving knowledge and intent to incorporate VExUS into clinical practice. This scalable digital tool may facilitate broader adoption of VExUS for optimized management in CRS and congestive AKI.

Acknowledgment

The authors thank Dr. Robert Hoover for conceiving the usability study design. App development was aided by Google Gemini.

VExUS.io interface displaying VExUS grading; icons at each step provide probe placement and reference waveform guidance.